| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |